Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery

Table 3

Pathological findings, hazard ratios, and values from univariable survival analysis ().

	(%)	Hazard ratio (95% CI)	value
Pathological complete response
No	187 (87%)	Reference	—
Yes	28 (13%)	0.1 (0.01-0.77)	0.03
ypT stage
T0	28 (13%)	0.09 (0.01-0.66)	0.02
T1	26 (12.1%)	0.46 (0.14-1.52)	0.20
T2	21 (9.8%)	0.43 (0.13-1.44)	0.17
T3	136 (63.3%)	Reference	—
T4	4 (1.9%)	1.33 (0.3-5.92)	0.70
Harvested lymph nodes		0.95 (0.92-0.98)	<0.01
ypN stage
N0	98 (45.6%)	Reference	—
N1	51 (23.7%)	1.83 (0.81-4.14)	0.15
N2	33 (15.3%)	2.0 (0.74-5.43)	0.17
N3a	26 (12.1%)	3.64 (1.42-9.35)	<0.01
N3b	7 (3.3%)	4.89 (1.36-17.6)	0.02
Vascular tumor embolus
No	175 (81.4%)	Reference	—
Yes	40 (18.6%)	2.31 (1.12-4.78)	0.02
Nerve invasion
No	143 (66.5%)	Reference	—
Yes	72 (33.5%)	2.03 (1.07-3.84)	0.03
HER2
(-)	117 (54.4%)	Reference	—
(+)~(++)	53 (24.7%)	1.22 (0.6-2.46)	0.58
(+++)	4 (1.9%)	5.57 (1.63-19)	<0.01
Data missing	41 (19.1%)